WallStreetZenWallStreetZen

How to Buy Aprea Therapeutics Stock

Aprea Therapeutics Inc

Aprea Therapeutics, Inc. , a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel cancer therapeutics that target DNA damage response pathways.

Aprea Therapeutics stock last closed at $5.17, down 3.72% from the previous day, and has increased 32.29% in one year. It has overperformed other stocks in the Biotechnology industry by 0.56 percentage points. Aprea Therapeutics stock is currently +85.97% from its 52-week low of $2.78, and -41.56% from its 52-week high of $8.85.

There are currently 5.43M APRE shares outstanding. The market cap of APRE is $28.07M. In the last 24 hours, 6305 APRE shares were traded.

How to Buy Aprea Therapeutics Stock

Not sure how to invest in Aprea Therapeutics stock? Here's how.
  1. Decide where to buy Aprea Therapeutics stock: You need to choose a stock brokerage, but don't worry - we've sifted through dozens of online brokerages and apps to help you choose where to buy Aprea Therapeutics stock.
  2. Open your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
  3. Fund your brokerage account: Select your method of payment and add your info.
  4. Evaluate Aprea Therapeutics stock: The Aprea Therapeutics ticker symbol is APRE. Is Aprea Therapeutics stock a good investment? Should you buy shares of APRE? How do APRE's underlying business fundamentals look? Do top analysts think Aprea Therapeutics is a good buy? Why has APRE's stock price moved recently? (Hint: Our stock research tools can help you decide if APRE is a good stock to buy).
  5. Make your APRE purchase: Decide if you will purchase APRE shares at the current market price or use a limit order to buy APRE shares at a particular price.
  6. Get notifications regarding your APRE investment: Create a watchlist to track your new investment in Aprea Therapeutics shares.

Step 1: Decide where to buy Aprea Therapeutics stock

You need a brokerage account to access the NASDAQ market and buy APRE shares.

A brokerage account allows you to buy and sell a number of investments, such as stocks, bonds, mutual funds, and ETFs.

Our preferred brokerage: eToro

Based on our experience, eToro is the best brokerage. eToro gives you:

  • Invest in stocks with zero commissions: Invest without commissions.
  • Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
  • Access to world markets: From Technology to Real Estate, New York to Shanghai — you can fill your portfolio with stocks from the world's top exchanges.
  • Social investing: eToro has a community with more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
  • Security: eToro is a regulated and licensed brokerage platform.
  • Buy other financial assets: Such as ETFs and cryptocurrencies.

Get $10 towards your stock purchase by creating an account with eToro now.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Open your brokerage account

Now that you've selected your brokerage, you need to fill out some personal info so you are able to buy APRE stock today.

How to Create a New Brokerage Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Provide your personal details to start your new brokerage account.
  1. Send your information by pressing the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Fund your brokerage account

Now that you have created your account on the best stock market app for beginners, you can securely and quickly fund your account:

Watch the tutorial below if you need help transferring money into your investment account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Evaluate Aprea Therapeutics stock

Once you have figured out the best place to buy Aprea Therapeutics stock, it's crucial to evaluate their stock before you invest, so you can wrap your head around the risk and opportunity.

Aprea Therapeutics shares data

APRE Price
$5.17
1w %
-9.77%
1y %
32.29%
5y %
N/A
P/E
-1.31x
P/B
1.66x
P/S
32.11x
PEG
N/A
Revenue
$583.23k
Earnings
-$14.29M
Fore. Rev. Growth
0.95%
Fore. Earn. Growth
N/A
Market Cap
$28.07M
Next Earnings
May 13, 2024
Next Dividend
N/A

Fundamentals of APRE

WallStreetZen was built to help average investors perform more in-depth fundamental analysis in minutes instead of hours.

You can see all of the due diligence checks on APRE's stock page.

What is the fair value of APRE stock?

Analysts use many financial metrics, analyses, models, and charts to gauge APRE's intrinsic value.

Using relative valuations methods:

  • APRE may be undervalued based on its P/B ratio of 1.66x, relative to Biotechnology industry P/B ratio of 5.86x

You can do more valuation research on APRE's stock here.

APRE Financial Health

Positive Financial Indicators:

  • There are more short-term assets than long-term liabilities on the APRE balance sheet.
  • APRE has cash burn of 12270701. It has sufficient cash and short-term investments to cover this for at least one year.
  • APRE has $21.65M in cash and short term investments. This is enough to cover its annual cash burn of $12.27M.
  • There are more short-term assets than short-term liabilities on the APRE balance sheet.
  • APRE has a low debt to equity ratio of 0.34.
  • Total APRE debt is lower than 5 years ago, relative to shareholder equity.

Negative Financial Indicators:

  • APRE profit margin has gone down from N/A to -2,449.6% in the past year.

Do analysts think it's a good time to buy Aprea Therapeutics stock

Out of 2 Wall Street analysts who monitor APRE, the consensus analyst rating on APRE is a Buy

It's important to note that analyst ratings are not stock recommendations, nor are they financial advice.

You can dive deeper into what analysts are forecasting on the Aprea Therapeutics stock forecast page.

Metrics for Advanced APRE Traders

SMA10
5.57
SMA20
5.95
SMA50
6.41
SMA100
5.66
SMA200
4.79
MACD
-0.31
MACD Signal
-0.23
MACD Histogram
-0.08
RSI
37.48
Stochastic %K
8.61
Stochastic %D
7.87
StochRSI %K
18.66
StochRSI %D
10.36

Who is buying/selling APRE?

Over the last 12 months, insiders at APRE have bought more shares than they have sold.

Oren Gilad, President CEO of APRE, was the latest APRE insider to buy. They bought $14,580.00 worth of APRE shares on Mar 13, 2024.

Get more info about who owns APRE shares here.

Can I rely on APRE as an income stream?

No, Aprea Therapeutics doesn't provide an income stream by paying out dividends.

What do other investors have to say about APRE?

One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.

Click below to see what other traders have to say.

Step 5: Make your APRE purchase

There are two primary types of orders:

  • Market order: A market order is an order to buy or sell a stock at the best possible price.
    Market orders are mostly sufficient.
  • Limit order: A limit order lets you buy or sell a stock at a specific price (or better).
    If you want to be certain you're buying or selling at a specific price, use a limit order.

Click the Open button and eToro will place the order.

If you want additional help with buying stocks on eToro, watch the helpful video below:

Open eToro Account

Step 6: Get notifications regarding your APRE investment

Now that you own some APRE shares, you'll want to stay up-to-date on your company.

Create a watchlist to track the latest developments regarding your APRE stock.

APRE Feed

How to Buy Stock in Aprea Therapeutics

To reiterate, here are the 6 steps for buying Aprea Therapeutics stock:

  1. Decide where to buy Aprea Therapeutics stock
  2. Open your brokerage account
  3. Fund your brokerage account
  4. Evaluate Aprea Therapeutics stock
  5. Make your APRE purchase
  6. Get notifications regarding your APRE investment

If you require a brokerage account, eToro is our favorite option.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you would like to get the latest news on your new investment in Aprea Therapeutics, create your watchlist below.

NASDAQ: APRE
$5.17-0.20 (-3.72%)
Updated Apr 24, 2024
Open eToro Account
NASDAQ: APRE
$5.17-0.20 (-3.72%)
Updated Apr 24, 2024
Open eToro Account

FAQ

How much does it cost to buy one Aprea Therapeutics share?

As of Apr 24, 2024, it costs $5.17 to buy one share of Aprea Therapeutics stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $2, you can buy 0.387 shares of APRE.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Aprea Therapeutics stock?

According to 2 Wall Street analysts who monitor Aprea Therapeutics, their consensus recommendation is to buy Aprea Therapeutics stock.

What is the best way to buy Aprea Therapeutics stock?

One way to place an order for Aprea Therapeutics stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.